Arsenal Capital Partners

Arsenal Capital Partners is a private equity firm founded in 2000 and headquartered in New York. The firm specializes in investing in lower middle-market companies, primarily within the healthcare and industrial sectors. Arsenal Capital Partners focuses on businesses operating in various industries, including business products and services, information technology, materials, resources, and manufacturing, primarily across the United States. As a Registered Investment Adviser, the firm is committed to providing investment services tailored to the unique needs of its portfolio companies.

Julia Bartimer

Associate

Ryan Berman

Principal

Michael Bernstein

Operating Partner

Kenny Breslow

Senior Associate

Daniel Bruck

Principal

Robert Cahill

Principal

Elana Caplan

Associate

Ian Chan

Vice President

Sean Chang

Associate

Ng We Chee

Vice President

Tony Clewlow

Vice President

Mike Colicchio

Co-Founder and Partner

Olivia Coyle

Associate

Sophie Critchfield-Jain

Vice President

John Digiovanni

Partner

Salvatore Gagliardo

Operating Partner

Kevin Grieve

Operating Partner

LaRae Harris

Associate

Marion Hayes

Senior Managing Director and Head of Responsible Investing

Taylor Holland

Principal

Chris Huetsch

Vice President

Christian Kohlmeyer

Associate

Jeffrey Kovach

MD

Jonathan Laifer

Principal

Marin Lang

Associate

Melanie Larkins

Vice President

Dylan LeDonne

Senior Associate

Alex Mansfield

Principal

Joelle Marquis

President

Jon Mattern

Principal

John Mattison

Operating Partner and Chief Medical Information Officer

Armand Della Monica

Operating Director

Terrence Mullen

Managing Partner

Drew Mullin

Partner

Michael J. O'Connor

Operating Partner

Daniel O'Sullivan

Associate

Brian Orkin

Investment Partner

Mark Pfister

Senior Associate

Barry Porter

Operating Partner

Nathan Press

Senior Associate

James Rock

Operating Partner

Joseph Rooney

Investment Partner

Brett Schneider

Operating Partner

Jacqueline Simek

Vice President, Finance

Robert Sorrel

Principal

David Spaight

Operating Partner

Harish Sriram

Senior Associate

John Televantos Ph.D

Senior Partner

Matthew Teller

Principal

Nick VanBelle

Associate

Alex Wada

Associate

Eric Wang

Associate

Haixiang Wang

Operating Partner

Robert Weiner

Associate

Jacob Weiss

Senior Associate

Matthew Whitman

Partner, Head of Origination

Timothy Zappala Ph.D

Senior Partner

Adetayo Zenger

Associate

Elisabetta Zhang

Managing Director and Head of Finance

Peter Huo Ph.D

Operating Partner

Past deals in New Jersey

WCG

Private Equity Round in 2019
WCG is a prominent provider of regulatory and ethical review services for human research, focusing on enhancing the quality and efficiency of clinical studies. The company reviews new research protocols and offers a range of services including clinical and human gene therapy research, laboratory biosafety consulting, and solutions for human research protections. WCG also provides online learning resources, an electronic informed consent solution to streamline clinical processes, oncology review services, and a cloud-based platform for managing research activities. Serving a diverse clientele that includes large pharmaceutical companies, biotechnology firms, and contract research organizations, WCG is committed to accelerating the delivery of new treatments while upholding high standards of human subject protection. Founded in 2012 and headquartered in Princeton, New Jersey, WCG operates multiple locations across the United States and in Tokyo, Japan, and has established a strategic partnership with InformedDNA.

Breen Color Concentrates

Acquisition in 2017
Breen Color has been providing custom color and additive concentrates to the plastics industry for over 30 years. Since its inception in 1976, Breen has grown in size and capability and has established itself as one of the leading suppliers of plastic colorants to the blow molding, wire and cable, extrusion/injection molding, compounding and roto-molding markets. Breen’s personal commitment to meeting the needs of the plastics industry is supported by a staff comprised of long term Breen employees and new additions of experienced professional managers in General Management, Sales and Marketing, Manufacturing, Technical and Finance. Breen’s formulation experience in a wide range of polymers has created a diverse portfolio of standard and custom color concentrates with which they can meet many of your immediate needs. Their extensive knowledge and database of pigment, resin and additive properties can also be utilized to rapidly develop custom color concentrates to meet any special requirement. Breen Color’s compounding equipment has been customized to provide rapid order turnaround while maintaining the exacting quality requirements of an ISO-9001 registered facility. Their pelletizing equipment is state-of-the-art and is capable of producing multiple pellet geometries. This ensures product consistency regardless of order size and provides the option of choosing the pellet form (diced, underwater cut or minibead) that works best in your application.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.